The anti-asparagines antibodies correlate withl-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia

10.1084/jem.118.1.99

10.1016/S1040-8428(98)00015-8

10.1002/mpo.2950180612

Nesbit M, 1979, Am J Pediatr Hematol Oncol, 1, 120

Cheung N K, 1986, Am J Pediatr Hematol Oncol, 19, 400

Asselin B L, 1993, J Clin Oncol, 11, 1780, 10.1200/JCO.1993.11.9.1780

10.1002/pbc.20064

10.1097/00043426-200404000-00002

Wahn V, 1983, Pediatr Pharmacol, 3, 303

10.1038/sj.leu.2401162

10.1038/sj.leu.2401973

10.1046/j.1365-2141.2000.02187.x

10.1002/1097-0142(197601)37:1<220::AID-CNCR2820370132>3.0.CO;2-W

Woo M H, 2000, J Clin Oncol, 18, 1525, 10.1200/JCO.2000.18.7.1525

10.1038/sj.leu.2401007

10.1002/mpo.10096

10.1007/s00280-002-0466-y